Sources | Names Used |
---|---|
GDSC1000 | HG-5-88-01 |
PharmacoGx | HG-5-88-01 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIDEB | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-06 |
mRNA | RFTN2 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-06 |
mRNA | ATL1 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-06 |
mRNA | IL6R | GDSC1000 | pan-cancer | AAC | 0.22 | 8e-06 |
mRNA | MYBPC2 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-05 |
mRNA | IFT172 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-05 |
mRNA | GAS1 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-05 |
mRNA | CHSY1 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-05 |
mRNA | RBM44 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-05 |
mRNA | ATP2B4 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-05 |